Tharimmune (THAR) Stock Is Surging Monday: What's Going On?

Shares of Tharimmune Inc (NASDAQ:THAR) are surging in Monday afternoon trading, continuing a rally that began last week. The stock’s rise comes in the absence of any company-specific news for the session, but follows last week’s announcement of promising simulation results for its lead clinical asset, TH104.

What To Know: TH104, a novel buccal film formulation of nalmefene, is being developed as a prophylactic countermeasure for military personnel and first responders who may be exposed to high-potency opioids like fentanyl.

Last week, Tharimmune announced positive results from a pharmacokinetic simulation analysis of TH104, highlighting its potential for rapid absorption and prolonged protection, offering a significant advantage over existing treatments like naloxone.

The company also announced that the U.S. Food and Drug Administration (FDA) has indicated that no additional clinical trials are necessary to support a 505(b)(2) New Drug Application submission. This streamlined pathway to potential approval has generated significant investor optimism amid the stock gaining over 500% in the past week.

The market’s continued positive reaction today, despite a lack of fresh news, suggests that investors could be pricing in the long-term potential of TH104.

Price Action: According to data from Benzinga Pro, THAR shares are trading higher by 67.16% to $7.89 Monday afternoon. The stock has a 52-week high of $9.08 and a 52-week low of $0.95.

Read Also: Argenx Targets FDA Label Expansion After Vyvgart Trial Success

How To Buy THAR Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Tharimmune’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

Image: Shutterstock